Ohlendorf, F., Werner, R. A., Henkenberens, C., Ross, T. L., Christiansen, H., Bengel, F. M., & Derlin, T. (2021). Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients with Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy. Diagnostics (Basel).
Citação norma ChicagoOhlendorf, Fiona, Rudolf A. Werner, Christoph Henkenberens, Tobias L. Ross, Hans Christiansen, Frank M. Bengel, and Thorsten Derlin. "Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients With Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy." Diagnostics (Basel) 2021.
MLA CitationOhlendorf, Fiona, et al. "Predictive and Prognostic Impact of Blood-Based Inflammatory Biomarkers in Patients With Gastroenteropancreatic Neuroendocrine Tumors Commencing Peptide Receptor Radionuclide Therapy." Diagnostics (Basel) 2021.